Patient companion apps + remote patient monitoring for MS

More than 1 million people in the United States are living with multiple sclerosis (MS), and worldwide that number rises to over 2.8 million. While disease-modifying treatments (DMTs) have provided many patients with relief and granted them a much better quality of life, up to 40% of patients are estimated to be receiving suboptimal treatments.

In this white paper, we're exploring several challenges in treating MS, including:

Patient-provider communication
Mental health issues
Treatment cost

We're also unpacking the role patient companion apps and Remote Patient Monitoring (RPM) can play in providing patients with better care. Useful digital health solutions provide a variety of tools, such as:

Caregiver portals
Seamless EHR integration
Real-world data capture for reimbursement

Download the white paper today to dive deeper into these topics and learn how BrightInsight's Digital Disease Management Solution is helping biopharma companies deliver digital solutions for MS.

Companion apps + RPM for MS